{"nct_id":"NCT02737501","title":"ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants","status":"COMPLETED","status_verified_date":"2021-07","start_date":"2016-05-26","start_date_type":"ACTUAL","primary_completion_date":"2020-07-28","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}